A Study of Ramucirumab and Paclitaxel in Patients With Solid Tumors
by on Tuesday, January 24th, 2012 | No Comments
Condition: Malignant Solid Tumour
Interventions: Biological: ramucirumab (IMC1121B); Drug: paclitaxel
Sponsor: ImClone LLC
Not yet recruiting – verified January 2012
Read more from the original source: A Study of Ramucirumab and Paclitaxel in Patients With Solid Tumors